EDITORIAL SECTION

Articles

Biosimilars in Europe: Expanding Access and Reducing Costs

The use of biosimilars as a part of modern health care systems is also fairly important especially in the context of the European Union as they can enhance the availability of the required treatments and reduce the costs of the health care sector As biologic medicines are recognized as firstline treatments for critical illnesses such as cancer autoimmune diseases and rheumatoid arthritis biosimila...

Unveiling the Revolutionary Potential: Exploring Blockchain Technology in Pharma

The pharmaceutical industry is renowned for its stringent regulations complex supply chains and crucial emphasis on data integrity In recent years the emergence of blockchain technology has sparked considerable interest

Strategic Synthesis: Shift to Continuous Manufacturing in Pharmaceuticals

The pharmaceutical industry is at a decisive inflection point necessitated by a move away from legacy batch processing toward Continuous Manufacturing CM This transition is no longer a peripheral innovation but a core strategic imperative for organizations seeking to maintain global competitiveness and uphold the highest standards

AI-Native R&D: Transforming Drug Discovery Through Intelligent Automation

For four decades pharmaceutical research productivity has moved stubbornly in the wrong direction A new medicine still takes ten to fifteen years to reach patients at a capitalised cost approaching US billion

Revolutionizing Health: The Future of Gene Editing and Genetic Engineering

In the realm of healthcare few advancements hold as much promise and controversy as gene editing and genetic engineering These technologies once confined to science fiction are now tangible tools

Trustworthy AI in Drug Discovery: From Innovation to Regulatory Readiness

Artificial intelligence is entering a new phase in drug discovery After years of enthusiasm for predictive models generative chemistry and automated screening attention is shifting from what AI can generate to whether its outputs can be trusted

Techno Trends

University of Dundee’s Cabamiquine Shows Promise for Single-Dose Malaria Treatment

Researchers at the University of Dundee have reported encouraging clinical results for cabamiquine a novel antimalarial compound being developed as a potential singledose treatment for malaria

Projects

Genentech to Invest US$750 Million in Oregon Device Fill-Finish Facility

Genentech a member of the Roche Group plans to invest approximately US million in a new device fillfinish manufacturing facility at its acre campus in Hillsboro Oregon The project will add endtoend manufacturing

Research Insights

Induction of osteogenic differentiation of MSCs by GSK3β knockdown through GSK3β siRNAs transfection

The development of effective strategies for treating bone defects can be based on gene therapy methods aimed at regulating the differentiation of osteoprogenitor cells One of the approaches is to use siRNA mo

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys